相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Deregulation and Targeting of TP53 Pathway in Multiple Myeloma
Katarina K. Jovanovic et al.
FRONTIERS IN ONCOLOGY (2019)
Various Signaling Pathways in Multiple Myeloma Cells and Effects of Treatment on These Pathways
Ali Dehghanifard et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2018)
Dose intensification of TRAIL-inducing ONC201 inhibits metastasis and promotes intratumoral NK cell recruitment
Jessica Wagner et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Mitochondrial MDM2 Regulates Respiratory Complex I Activity Independently of p53
Giuseppe Arena et al.
MOLECULAR CELL (2018)
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Daniel E. Johnson et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Interpreting clinical trial data in multiple myeloma: translating findings to the real-world setting
Paul G. Richardson et al.
BLOOD CANCER JOURNAL (2018)
Second primary malignancies in multiple myeloma: an overview and IMWG consensus (vol 28, pg 228, 2017)
P. Musto et al.
ANNALS OF ONCOLOGY (2018)
Targeting mutant p53 for efficient cancer therapy
Vladimir J. N. Bykov et al.
NATURE REVIEWS CANCER (2018)
Nelfinavir inhibits proliferation and induces DNA damage in thyroid cancer cells
Kirk Jensen et al.
ENDOCRINE-RELATED CANCER (2017)
Effects of the Notch1 signaling pathway on human lung cancer A549 cells
Yun Zeng et al.
EXPERIMENTAL LUNG RESEARCH (2017)
Apigenin, by activating p53 and inhibiting STAT3, modulates the balance between pro-apoptotic and pro-survival pathways to induce PEL cell death
Marisa Granato et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Targeting of cell cycle and let-7a/STAT3 pathway by niclosamide inhibits proliferation, migration and invasion in oral squamous cell carcinoma cells
Xiaoxu Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
STAT3:FOXM1 and MCT1 drive uterine cervix carcinoma fitness to a lactate-rich microenvironment
Lidia Santos Silva et al.
TUMOR BIOLOGY (2016)
Small Molecular TRAIL Inducer ONC201 Induces Death in Lung Cancer Cells: A Preclinical Study
Yuan Feng et al.
PLOS ONE (2016)
Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway
Joshua E. Allen et al.
MOLECULAR CANCER (2015)
STAT3 Target Genes Relevant to Human Cancers
Richard L. Carpenter et al.
CANCERS (2014)
Dual Inactivation of Akt and ERK by TIC10 Signals Foxo3a Nuclear Translocation, TRAIL Gene Induction, and Potent Antitumor Effects
Joshua E. Allen et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Metabolomics-on-a-Chip of Hepatotoxicity Induced by Anticancer Drug Flutamide and Its Active Metabolite Hydroxyflutamide Using HepG2/C3a Microfluidic Biochips
Leila Choucha Snouber et al.
TOXICOLOGICAL SCIENCES (2013)
Panobinostat for the treatment of multiple myeloma
Paola Neri et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
In Vitro and In Vivo Selective Antitumor Activity of a Novel Orally Bioavailable Proteasome Inhibitor MLN9708 against Multiple Myeloma Cells
Dharminder Chauhan et al.
CLINICAL CANCER RESEARCH (2011)
MEDICAL PROGRESS Multiple Myeloma
Antonio Palumbo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
SNX-2112, a selective Hsp90 inhibitor, potently inhibits tumor cell growth, angiogenesis, and osteoclastogenesis in multiple myeloma and other hematologic tumors by abrogating signaling via Akt and ERK
Yutaka Okawa et al.
BLOOD (2009)
Natural polyphenols antagonize the antimyeloma activity of proteasome inhibitor bortezomib by direct chemical interaction
Tae Young Kim et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Cyclin-dependent kinases: a family portrait
Marcos Malumbres et al.
NATURE CELL BIOLOGY (2009)
Cell cycle, CDKs and cancer: a changing paradigm
Marcos Malumbres et al.
NATURE REVIEWS CANCER (2009)
Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome
Herve Avet-Loiseau et al.
BLOOD (2007)
A novel orally active small molecule potently induces G1 arrest in primary myeloma cells and prevents tumor growth by specific inhibition of cyclin-dependent kinase 4/6
Linda B. Baughn et al.
CANCER RESEARCH (2006)
Phosphorylation of serine 18 regulates distinct p53 functions in mice
HK Sluss et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Cell cycle regulation of central spindle assembly
M Mishima et al.
NATURE (2004)
分享论文
